Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 98
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Clin Exp Pharmacol Physiol ; 51(3): e13837, 2024 03.
Artículo en Inglés | MEDLINE | ID: mdl-38302081

RESUMEN

Although it is well established that fibromyalgia (FM) syndrome is characterized by chronic diffuse musculoskeletal hyperalgesia, very little is known about the effect of this pathology on muscle tissue plasticity. Therefore, the present study aimed to characterize the putative alterations in skeletal muscle mass in female rats subjected to a FM model by inducing chronic diffuse hyperalgesia (CDH) through double injections of acidic saline (pH 4.0) into the left gastrocnemius muscle at 5-day intervals. To determine protein turnover, the total proteolysis, proteolytic system activities and protein synthesis were evaluated in oxidative soleus muscles of pH 7.2 (control) and pH 4.0 groups at 7 days after CDH induction. All animals underwent behavioural analyses of mechanical hyperalgesia, strength and motor performance. Our results demonstrated that, in addition to hyperalgesia, rats injected with acidic saline exhibited skeletal muscle loss, as evidenced by a decrease in the soleus fibre cross-sectional area. This muscle loss was associated with increased proteasomal proteolysis and expression of the atrophy-related gene (muscle RING-finger protein-1), as well as reduced protein synthesis and decreased protein kinase B/S6 pathway activity. Although the plasma corticosterone concentration did not differ between the control and pH 4.0 groups, the removal of the adrenal glands attenuated hyperalgesia, but it did not prevent the increase in muscle protein loss in acidic saline-injected animals. The data suggests that the stress-related hypothalamic-pituitary-adrenal axis is involved in the development of hyperalgesia, but is not responsible for muscle atrophy observed in the FM model induced by intramuscular administration of acidic saline. Although the mechanisms involved in the attenuation of hyperalgesia in rats injected with acidic saline and subjected to adrenalectomy still need to be elucidated, the results found in this study suggest that glucocorticoids may not represent an effective therapeutic approach to alleviate FM symptoms.


Asunto(s)
Fibromialgia , Hiperalgesia , Ratas , Femenino , Animales , Hiperalgesia/tratamiento farmacológico , Fibromialgia/complicaciones , Fibromialgia/tratamiento farmacológico , Fibromialgia/patología , Adrenalectomía , Sistema Hipotálamo-Hipofisario/metabolismo , Sistema Hipotálamo-Hipofisario/patología , Sistema Hipófiso-Suprarrenal/metabolismo , Sistema Hipófiso-Suprarrenal/patología , Músculo Esquelético/metabolismo , Atrofia Muscular/patología , Solución Salina/farmacología
2.
Homeopathy ; 2024 Jul 08.
Artículo en Inglés | MEDLINE | ID: mdl-38977001

RESUMEN

Homeopathy was introduced in Brazil with the French doctor Benoît Jules Mure's arrival in 1840 and was officially recognised in 1980 as a medical specialty by Brazilian regulatory authorities. Public health policies played an important role in incorporating homeopathy into the Brazilian Unified Health System (SUS), emphasising homeopathy's coherence with SUS's fundamental principles and with other national health policies. Homeopathy is supported by the guidelines of the National Primary Health Care Policy and the National Policy on Integrative and Complementary Practices, and its offer in the SUS has been recognised since 2006. Challenges persist, however, such as the low prevalence of the use of homeopathy, lack of investment in professional training and under-reporting of homeopathy outpatient appointments. Investments in disseminating information on homeopathic philosophy and raising awareness among managers and health professionals are essential to strengthen its presence in the Brazilian public health system.

3.
BMC Oral Health ; 24(1): 1114, 2024 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-39300380

RESUMEN

BACKGROUND: To verify the influence of macrogeometry with healing chambers on the osseointegration of dental implants by analyzing implant stability quotient (ISQ) and evaluate the correlation between insertion torque and ISQ insertion with different macrogeometries. METHODS: In total, 26 implants were installed in the posterior mandible of eight patients with sufficient bone height for the installation of implants measuring 3.5 mm in diameter and 9.0 mm in length. The implants were categorized according to two types of macrogeometry: a test group (GT) with 13 conical implants with healing chambers and a control group (GC) with 13 conical implants with conventional threads. To insert the implants, a bone drilling protocol was used up to a diameter of 3 mm with the last helical bur. The insertion torque of the implants was evaluated, followed by the measurement of ISQ at 0 (T-0), 7 (T-7), 14 (T-14), 21 (T-21), 28 (T-28), and 42 (T-42) days. RESULTS: The mean insertion torque was 43 Ncm in both groups, without a significant difference. Moreover, no significant difference in the ISQ values was found between the groups at different time points (p > 0.05), except at T-7 (GT = 69.87±1.89 and GC = 66.48±4.49; p = 0.01). Although there was no significant difference, ISQ median values were higher in the GT group than GC group at 28 days (GT = 67.98 and GC = 63.46; p = 0.05) and 42 days (GT = 66.12 and GC = 60.33; p = 0.09). No correlation was found between the insertion torque and ISQ insertion (p > 0.05). CONCLUSION: Furthermore, implants with a 3.5 mm diameter macrogeometry, with or without healing chambers, inserted with a drilling protocol up to 3 mm in diameter of the last helical bur, led to a similar secondary stability, with no difference in ISQ values. Although, implants with healing chamber demonstrates ascending values in the graph of ISQ, having a trend of faster osseointegration than implants without healing chambers. Both macrogeometries provide a similar primary stability to implants. TRIAL REGISTRATION: This study was registered retrospectively in ReBec (brazilian registry of clinical trials) under the number RBR-96n5×69, on the date of 19/06/2023.


Asunto(s)
Implantación Dental Endoósea , Implantes Dentales , Mandíbula , Oseointegración , Torque , Humanos , Oseointegración/fisiología , Implantación Dental Endoósea/métodos , Masculino , Femenino , Persona de Mediana Edad , Mandíbula/cirugía , Diseño de Prótesis Dental , Adulto , Cicatrización de Heridas , Anciano , Retención de Prótesis Dentales , Propiedades de Superficie
4.
Microb Pathog ; 181: 106166, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37290729

RESUMEN

Candida albicans is one of the leading pathological agents of mucosal and deep tissue infections. Considering that the variety of antifungals is restricted and that toxicity limits their use, immunotherapies against pathogenic fungi have been viewed as alternatives with reduced adverse effects. In this context, C. albicans has a protein used to capture iron from the environment and the host, known as the high-affinity iron permease Ftr1. This protein may be a new target of action for novel antifungal therapies, as it influences the virulence of this yeast. Thus, the aim of the present study was to produce and conduct the biological characterization of IgY antibodies against C. albicans Ftr1. Immunization of laying hens with an Ftr1-derived peptide resulted in IgY antibodies extracted from egg yolks capable of binding to the antigen with high affinity (avidity index = 66.6 ± 0.3%). These antibodies reduced the growth and even eliminated C. albicans under iron restriction, a favorable condition for the expression of Ftr1. This also occurred with a mutant strain that does not produce Ftr1 in the presence of iron, a circumstance in which the protein analog of iron permease, Ftr2, is expressed. Furthermore, the survival of G. mellonella larvae infected with C. albicans and treated with the antibodies was 90% higher than the control group, which did not receive treatment (p < 0.0001). Therefore, our data suggest that IgY antibodies against Ftr1 from C. albicans can inhibit yeast propagation by blocking iron uptake.


Asunto(s)
Candida albicans , Mariposas Nocturnas , Animales , Femenino , Antifúngicos/farmacología , Antifúngicos/metabolismo , Hierro/metabolismo , Proteínas de Transporte de Membrana/genética , Proteínas de Transporte de Membrana/metabolismo , Pollos , Anticuerpos
5.
Crit Care ; 27(1): 128, 2023 03 30.
Artículo en Inglés | MEDLINE | ID: mdl-36998022

RESUMEN

BACKGROUND: Patient-ventilator asynchronies are usually detected by visual inspection of ventilator waveforms but with low sensitivity, even when performed by experts in the field. Recently, estimation of the inspiratory muscle pressure (Pmus) waveforms through artificial intelligence algorithm has been proposed (Magnamed®, São Paulo, Brazil). We hypothesized that the display of these waveforms could help healthcare providers identify patient-ventilator asynchronies. METHODS: A prospective single-center randomized study with parallel assignment was conducted to assess whether the display of the estimated Pmus waveform would improve the correct identification of asynchronies in simulated clinical scenarios. The primary outcome was the mean asynchrony detection rate (sensitivity). Physicians and respiratory therapists who work in intensive care units were randomized to control or intervention group. In both groups, participants analyzed pressure and flow waveforms of 49 different scenarios elaborated using the ASL-5000 lung simulator. In the intervention group the estimated Pmus waveform was displayed in addition to pressure and flow waveforms. RESULTS: A total of 98 participants were included, 49 per group. The sensitivity per participant in identifying asynchronies was significantly higher in the Pmus group (65.8 ± 16.2 vs. 52.94 ± 8.42, p < 0.001). This effect remained when stratifying asynchronies by type. CONCLUSIONS: We showed that the display of the Pmus waveform improved the ability of healthcare professionals to recognize patient-ventilator asynchronies by visual inspection of ventilator tracings. These findings require clinical validation. TRIAL REGISTRATION: ClinicalTrials.gov: NTC05144607. Retrospectively registered 3 December 2021.


Asunto(s)
Inteligencia Artificial , Respiración Artificial , Humanos , Brasil , Atención a la Salud , Personal de Salud , Músculos , Estudios Prospectivos , Ventiladores Mecánicos
6.
Int J Mol Sci ; 24(21)2023 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-37958867

RESUMEN

The skin is essential to the integrity of the organism. The disruption of this organ promotes a wound, and the organism starts the healing to reconstruct the skin. Copaifera langsdorffii is a tree used in folk medicine to treat skin affections, with antioxidant and anti-inflammatory properties. In our study, the oleoresin of the plant was associated with nanostructured lipid carriers, aiming to evaluate the healing potential of this formulation and compare the treatment with reference drugs used in wound healing. Male Wistar rats were used to perform the excision wound model, with the macroscopic analysis of wound retraction. Skin samples were used in histological, immunohistochemical, and biochemical analyses. The results showed the wound retraction in the oleoresin-treated group, mediated by α-smooth muscle actin (α-SMA). Biochemical assays revealed the anti-inflammatory mechanism of the oleoresin-treated group, increasing interleukin-10 (IL-10) concentration and decreasing pro-inflammatory cytokines. Histopathological and immunohistochemical results showed the improvement of re-epithelialization and tissue remodeling in the Copaifera langsdorffii group, with an increase in laminin-γ2, a decrease in desmoglein-3 and an increase in collagen remodeling. These findings indicate the wound healing potential of nanostructured lipid carriers associated with Copaifera langsdorffii oleoresin in skin wounds, which can be helpful as a future alternative treatment for skin wounds.


Asunto(s)
Fabaceae , Repitelización , Ratas , Animales , Ratas Wistar , Piel/patología , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Fabaceae/química , Lípidos
7.
J Evid Based Dent Pract ; 23(2): 101834, 2023 06.
Artículo en Inglés | MEDLINE | ID: mdl-37201974

RESUMEN

BACKGROUND: Nosocomial pneumonia ranks among the top 5 diseases that lead to additional financial costs due to hospitalization. This study aimed to evaluate the cost of oral care and its clinical effectiveness in preventing pneumonia in a systematic review. METHODS: The search was conducted in the following databases: PubMed, Cochrane Library, Web of Sciences, Scopus, CINAHL, LILACS, complemented by gray literature and manual search, between January/2021 and August/2022. Two independent reviewers extracted data from the selected articles, individually analyzing each study's quality using the BMJ Drummond checklist. The data were tabulated by clinical or economic type. RESULTS: A total of 3,130 articles were identified; the eligibility criteria were verified, and 12 articles were selected for qualitative analysis. Only 2 achieved satisfactory quality assessment for economic analysis studies. There was heterogeneity between clinical and economic data. Eleven of the 12 studies reported a decrease in the incidence of nosocomial pneumonia following the application of oral care practices. Most authors reported a reduction in the estimate of individual costs, followed by a decrease in the need for antibiotic therapy. The costs of oral care were very low compared to other costs. CONCLUSIONS: Despite the low level of evidence in the literature, heterogeneity and poor quality of the selected studies, most studies concluded that oral care seemed to lead to reduced costs in hospital expenses for treating pneumonia.


Asunto(s)
Infección Hospitalaria , Neumonía Asociada a la Atención Médica , Neumonía , Humanos , Infección Hospitalaria/prevención & control , Neumonía Asociada a la Atención Médica/prevención & control , Neumonía/prevención & control , Antibacterianos/uso terapéutico , Resultado del Tratamiento
8.
J Cell Sci ; 133(14)2020 07 21.
Artículo en Inglés | MEDLINE | ID: mdl-32576665

RESUMEN

Bone morphogenetic protein 9 (BMP9) and BMP10 are circulating ligands that mediate endothelial cell (EC) protection via complexes of the type I receptor ALK1 and the type II receptors activin type-IIA receptor (ACTR-IIA) and bone morphogenetic type II receptor (BMPR-II). We previously demonstrated that BMP9 induces the expression of interleukin-6, interleukin-8 and E-selectin in ECs and might influence their interactions with monocytes and neutrophils. We asked whether BMP9 and BMP10 regulate the expression of chemokine (C-C motif) ligand 2 (CCL2), a key chemokine involved in monocyte-macrophage chemoattraction. Here, we show that BMP9 and BMP10 repress basal CCL2 expression and release from human pulmonary artery ECs and aortic ECs. The repression was dependent on ALK1 and co-dependent on ACTR-IIA and BMPR-II. Assessment of canonical Smad signalling indicated a reliance of this response on Smad4. Of note, Smad1/5 signalling contributed only at BMP9 concentrations similar to those in the circulation. In the context of inflammation, BMP9 did not alter the induction of CCL2 by TNF-α. As CCL2 promotes monocyte/macrophage chemotaxis and endothelial permeability, these data support the concept that BMP9 preserves basal endothelial integrity.


Asunto(s)
Células Endoteliales , Factor 2 de Diferenciación de Crecimiento , Receptores de Activinas Tipo II , Proteínas Morfogenéticas Óseas , Quimiocina CCL2/genética , Factor 2 de Diferenciación de Crecimiento/genética , Humanos , Factores Protectores
9.
Cleft Palate Craniofac J ; 59(8): 1056-1063, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-34259068

RESUMEN

OBJECTIVE: To examine oral colonization and virulence factors of Candida spp. in patients aged from 0 to 18 months with cleft palate (CP). MATERIALS AND METHODS: Sixty babies were allocated into 3 groups: CP, CP with orthodontic plate (CPwP), and control group (Ctrl) without CP. Information on feeding habits, hygiene, and history of candidosis was collected. The presence of Candida spp. was investigated in samples of saliva. Fungal hydrophobicity, protease, esterase, phospholipase, and hemolysin were evaluated in a semiquantitative manner. RESULTS: Positive oral isolations of Candida spp. were detected in CP (89.5%), CPwP (100%), and Ctrl (44%) groups. Candidosis was more reported in the cleft groups than in the Ctrl group (P ≤ .023). There was a higher prevalence of Candida albicans, followed by Candida krusei, Candida tropicalis, and Candida parapsilosis in all groups. There was no uniformity of expression of virulence factors, either among different species or among different groups. CONCLUSION: Candida spp. colonization occurred in all groups, being superior in CPwP group. Candidosis episodes were more reported in patients from CPwP than in other groups, although candidosis was also registered in other groups. Candida albicans was the predominant species and virulence factors did not exhibit any pattern for species or groups of patients.


Asunto(s)
Candida , Fisura del Paladar , Candida/metabolismo , Humanos , Lactante , Saliva/microbiología , Factores de Virulencia/metabolismo
10.
NMR Biomed ; 34(8): e4560, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34086382

RESUMEN

In many tumors, cancer cells take up large quantities of glucose and metabolize it into lactate, even in the presence of sufficient oxygen to support oxidative metabolism. It has been hypothesized that this malignant metabolic phenotype supports cancer growth and metastasis, and that reversal of this so-called "Warburg effect" may selectively harm cancer cells. Conversion of glucose to lactate can be reduced by ablation or inhibition of lactate dehydrogenase (LDH), the enzyme responsible for conversion of pyruvate to lactate at the endpoint of glycolysis. Recently developed inhibitors of LDH provide new opportunities to investigate the role of this metabolic pathway in cancer. Here we show that magnetic resonance spectroscopic imaging of hyperpolarized pyruvate and its metabolites in models of breast and lung cancer reveal that inhibition of LDH was readily visualized through reduction in label exchange between pyruvate and lactate, while genetic ablation of the LDH-A isoform alone had smaller effects. During the acute phase of LDH inhibition in breast cancer, no discernible bicarbonate signal was observed and small signals from alanine were unchanged.


Asunto(s)
Neoplasias de la Mama/enzimología , Eliminación de Gen , Lactato Deshidrogenasa 5/antagonistas & inhibidores , Lactato Deshidrogenasa 5/genética , Neoplasias Pulmonares/enzimología , Espectroscopía de Resonancia Magnética , Ácido Pirúvico/metabolismo , Animales , Proteína BRCA1/metabolismo , Neoplasias de la Mama/diagnóstico por imagen , Femenino , Lactato Deshidrogenasa 5/metabolismo , Neoplasias Pulmonares/diagnóstico por imagen , Ratones , Transportadores de Ácidos Monocarboxílicos/metabolismo , Proteínas Musculares/metabolismo , Piridonas/administración & dosificación , Piridonas/farmacología , Simportadores/metabolismo , Tiofenos/administración & dosificación , Tiofenos/farmacología
11.
Arch Microbiol ; 201(8): 1025-1028, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31101955

RESUMEN

Brucellosis is an infectious disease caused by bacteria of the genus Brucella, which affects domestic animals and is transmissible to humans. The objective of this study was to evaluate six methods of DNA extraction directly from bovine tissue to detect Brucella spp. The Cq values for all samples were above 30 and varied according to the extraction kit used, but four kits showed no statistical difference in sensitivity. This work demonstrates the importance of choosing the best extraction kit before validation of a molecular diagnostic technique.


Asunto(s)
Brucella/genética , Brucelosis/diagnóstico , Brucelosis/veterinaria , Enfermedades de los Bovinos/diagnóstico , ADN Bacteriano/genética , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Animales , Animales Domésticos/microbiología , Brucella/clasificación , Brucella/aislamiento & purificación , Brucelosis/microbiología , Bovinos , Enfermedades de los Bovinos/microbiología , Humanos , Técnicas de Diagnóstico Molecular/veterinaria , Sensibilidad y Especificidad
12.
Ecotoxicol Environ Saf ; 147: 64-71, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28837871

RESUMEN

The present work reports the preparation of activated carbon fibers (ACFs) from pineapple plant leaves, and its application on caffeine (CFN) removal from aqueous solution. The preparation procedure was carried out using the H3PO4 as activating agent and slow pyrolysis under N2 atmosphere. The characterization of materials was performed from the N2 adsorption and desorption isotherms, scanning electron microscopy (SEM), thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Raman spectroscopy, Boehm titration and pHpzc method. ACFs showed high BET surface area value (SBET = 1031m2 g-1), well-developed mesoporous structure (mesopore volume of 1.27cm³ g-1) and pores with average diameter (DM) of 5.87nm. Additionally, ACFs showed features of fibrous material with predominance of acid groups on its surface. Adsorption studies indicated that the pseudo-second order kinetic and Langmuir isotherm models were that best fitted to the experimental data. The monolayer adsorption capacity was found to be 155.50mgg-1. thermodynamic studies revealed that adsorption process is spontaneous, exothermic and occurs preferably via physisorption. The pineapple leaves are an efficient precursor for preparation of ACFs, which were successful applied as adsorbent material for removal of caffeine from the aqueous solutions.


Asunto(s)
Ananas/química , Cafeína/análisis , Carbono/química , Hojas de la Planta/química , Contaminantes Químicos del Agua/análisis , Purificación del Agua/métodos , Adsorción , Brasil , Fibra de Carbono , Carbón Orgánico/química , Cinética , Modelos Teóricos , Termodinámica
13.
Clin Oral Investig ; 22(3): 1403-1409, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29022137

RESUMEN

OBJECTIVES: This study aims to evaluate the effect of different endodontic sealers (epoxy resin, eugenol, and bioceramic/calcium silicate-based) and the time of cementation (immediately or 7 days after canal obturation) on the bond strength of a fiberglass post cemented with RelyX™ ARC. MATERIAL AND METHODS: Eighty-four premolars were instrumented and divided into groups (n = 12) according to the sealer and the time of post cementation: Endofill (EN), Endosequence BC Sealer (BC), and AH Plus (AH) had immediately fiber post cementation; EN7, BC7, and AH7 had post cementation after 7 days; and control group (C) had fiber post cementation without endodontic sealer. Each post space of the root was cut into slices and submitted to push-out test. Failure mode was assessed. Two-way ANOVA, Tukey's, and Dunnett's tests were used for statistical analysis (α = 5%). RESULTS: The type of endodontic sealer (p < 0.001), the time of post cementation (p = 0.038), and the interaction sealer time (p = 0.002) had negative influence on bond strength of fiberglass posts cemented with RelyX™ ARC. AH promoted the highest bond strength mean values (21.20 MPa immediately and 15.54 MPa at 7 days). EN (9.75 MPa immediately and 13.15 MPa at 7 days) and BC (10.43 MPa immediately and 5.73 MPa at 7 days) had lower bond strength than AH, regardless the time of cementation. CONCLUSIONS: AH was the best sealer to obturate the root canal when fiberglass cementation with resin-based cement is planned. CLINICAL RELEVANCE: The correct choice of an endodontic sealer and the adequate time of post cementation may avoid post dislocation caused by low bond strength to dentin.


Asunto(s)
Cementación/métodos , Recubrimiento Dental Adhesivo , Técnica de Perno Muñón , Materiales de Obturación del Conducto Radicular/química , Diente Premolar , Bisfenol A Glicidil Metacrilato/química , Compuestos de Calcio/química , Fosfatos de Calcio/química , Combinación de Medicamentos , Resinas Epoxi/química , Eugenol/química , Vidrio/química , Humanos , Técnicas In Vitro , Ensayo de Materiales , Óxidos/química , Polietilenglicoles/química , Ácidos Polimetacrílicos/química , Obturación del Conducto Radicular , Silicatos/química , Estrés Mecánico , Propiedades de Superficie
14.
Immunology ; 150(1): 115-126, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27618667

RESUMEN

The clinical benefits of short-term therapy with glucocorticoids (GC) in patients with inflammatory bowel disease (IBD) are widely known. However, the effects of this treatment towards the re-establishment of the regulatory network in IBD are not fully explored. We have evaluated the immunological effects of the abbreviated GC therapy in experimental colitis induced by 3% dextran sulphate sodium in C57BL/6 mice. Treatment with GC improved disease outcome, constrained circulating leucocytes and ameliorated intestinal inflammation. The control of the local inflammatory responses involved a reduction in the expression of interferon-γ and interleukin-1ß, associated with augmented mRNA levels of peroxisome proliferator-activated receptors (α and γ) in intestine. Furthermore, there was a reduction of CD4+ T cells producing interferon-γ, together with an increased frequency of the putative regulatory population of T cells producing interleukin-10, in spleen. These systemic alterations were accompanied by a decrease in the proliferative potential of splenocytes of mice treated in vivo with GC. Notably, treatment with GC also led to an increase in the frequency of the regulatory markers GITR, CTLA-4, PD-1, CD73 and FoxP3, more prominently in spleen. Taken together, our results pointed to a role of GC in the control of leucocyte responsiveness and re-establishment of a regulatory system, which probably contributed to disease control and the restoration of immune balance. Finally, this is the first time that GC treatment was associated with the modulation of a broad number of regulatory markers in an experimental model of colitis.


Asunto(s)
Colitis/tratamiento farmacológico , Glucocorticoides/uso terapéutico , Subgrupos de Linfocitos T/inmunología , Linfocitos T Reguladores/inmunología , Animales , Antígenos CD4/metabolismo , Células Cultivadas , Protocolos Clínicos , Colitis/inducido químicamente , Sulfato de Dextran , Proteína Relacionada con TNFR Inducida por Glucocorticoide/metabolismo , Humanos , Inmunomodulación , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Interleucina-1beta/metabolismo , Masculino , Ratones , Receptores Activados del Proliferador del Peroxisoma/metabolismo
15.
Org Biomol Chem ; 15(40): 8606-8613, 2017 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-28980694

RESUMEN

PD1n-3 DPA is a specialized pro-resolving lipid mediator that displays potent anti-inflammatory properties and pro-resolving bioactivities. Such naturally occurring compounds are of current interest in biomolecular chemistry and drug discovery. To investigate the involvement of an epoxide intermediate in the biosynthesis of PD1n-3 DPA from n-3 docosapentaenoic acid, the epoxy acid 16(S),17(S)-epoxy-PDn-3 DPA, herein named ePDn-3 DPA, was prepared by stereoselective total synthesis. The synthetic material of ePDn-3 DPA allowed investigations of its role in the biosynthesis of PD1n-3 DPA. The obtained results establish that the biosynthesis of PD1n-3 DPA in neutrophils occurs with ePDn-3 DPA as the intermediate, and that 15-LOX produces ePDn-3 DPA from n-3 docosapentaenoic acid. Furthermore, support for the involvement of a hydrolytic enzyme in the biosynthetic conversion of ePDn-3 DPA to PD1n-3 DPA was found. In addition, ePDn-3 DPA was found to regulate the formation of the potent neutrophil chemoattractant LTB4 with equal potencies to that obtained with PD1n-3 DPA.


Asunto(s)
Antiinflamatorios/metabolismo , Antiinflamatorios/farmacología , Compuestos Epoxi/metabolismo , Ácidos Grasos Insaturados/biosíntesis , Antiinflamatorios/química , Araquidonato 15-Lipooxigenasa/metabolismo , Compuestos Epoxi/química , Compuestos Epoxi/farmacología , Ácidos Grasos Insaturados/química , Ácidos Grasos Insaturados/farmacología , Humanos , Leucotrieno B4/antagonistas & inhibidores , Leucotrieno B4/biosíntesis , Leucotrieno B4/química , Estructura Molecular , Neutrófilos/química , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Estereoisomerismo
16.
Int Arch Allergy Immunol ; 169(2): 121-4, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27055122

RESUMEN

BACKGROUND: Current guidelines on chronic spontaneous urticaria (CSU) suggest a treatment based on a 3-step approach that aims at total symptom control, starting with H1-antihistamines. However, a significant number of patients present an antihistamine-resistant urticaria that must be treated with an alternative third-line therapy such as omalizumab. METHODS: Patients with a history of CSU who did not respond to treatment with high doses of modern antihistamines were treated with 150 or 300 mg of omalizumab every 4 weeks. The response to treatment was recorded as complete (CR), partial (PR) or no response. A dose adjustment was proposed according to response. RESULTS: We treated 47 CSU patients with omalizumab (40 females), of whom 39.5% had evidence of autoimmunity. The average number of treatments was 11.4 (range 2-87). All patients had been refractory to high-dose modern antihistamines. A CR was seen in 84.6% of patients who started with 300 mg and in 60% of those who started with 150 mg. Only 1 patient had no response to both the 150- and 300-mg doses. In 6 of the PR patients with 150 mg, a higher dose of 300 mg was proposed and 4 had a CR. Four patients discontinued the treatment. No severe adverse events were reported in the patients who finished the study. DISCUSSION: Although good results were seen in both groups, CR rates were higher in those under a high-dose initial treatment. Our data strongly suggest that the therapy should be individualized.


Asunto(s)
Antialérgicos/uso terapéutico , Omalizumab/uso terapéutico , Urticaria/tratamiento farmacológico , Urticaria/inmunología , Adolescente , Adulto , Anciano , Antialérgicos/administración & dosificación , Brasil , Enfermedad Crónica , Resistencia a Medicamentos , Femenino , Antagonistas de los Receptores Histamínicos/uso terapéutico , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Masculino , Persona de Mediana Edad , Omalizumab/administración & dosificación , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
17.
Neuroimmunomodulation ; 23(1): 58-66, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26886382

RESUMEN

OBJECTIVES: Toll-like receptors (TLRs) are expressed in several immune cells including blood monocytes and resident macrophages, such as microglia in the central nervous system. TLRs recognize pathogen- or damage-associated molecular patterns, leading to the release of inflammatory and toxic molecules, which can contribute to neuroinflammation associated with Parkinson's disease (PD). The aim of this study was to compare the potential of peripheral blood cells from PD patients or healthy subjects to produce cytokines after exposure to TLR agonists, and to investigate TLR2 and TLR4 expression on monocyte subsets. METHODS: Twenty-one patients and 21 healthy controls were recruited. Patients were evaluated according to the Unified Parkinson's Disease Rating Scale, and Hoehn and Yahr stage. Cytokines were measured in supernatants of whole blood cultures after incubation with TLR2, TLR4, or TLR7/8 agonists, by cytometric bead array. Expression of CD14, CD16, TLR2, and TLR4 was analyzed by cytometry. RESULTS: Patient blood cells produced lower levels of cytokines in response to TLR2 and also after TLR7/8/R848 activation than controls. Percentages of CD14+CD16+ or CD14+CD16- monocytes and TLR2 and TLR4 expression were similar between patients and controls. CONCLUSIONS: Blood leukocyte TLR2 and TLR7/8 responses are impaired in PD. This was neither associated with imbalance in monocyte subsets nor with TLR2/TLR4 expression on these cells. The association between a decreased TLR response in periphery and damage of brain in PD must be further investigated.


Asunto(s)
Células Sanguíneas/metabolismo , Citocinas/metabolismo , Enfermedad de Parkinson/sangre , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 7/metabolismo , Anciano , Células Sanguíneas/efectos de los fármacos , Estudios de Casos y Controles , Células Cultivadas , Relación Dosis-Respuesta a Droga , Femenino , Citometría de Flujo , Humanos , Imidazoles/farmacología , Lipopolisacáridos/farmacología , Lipoproteínas/farmacología , Masculino , Persona de Mediana Edad , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Estadística como Asunto
18.
Mediators Inflamm ; 2016: 4936370, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27403034

RESUMEN

The adrenal glands are able to modulate immune responses through neuroimmunoendocrine interactions and cortisol secretion that could suppress exacerbated inflammation such as in inflammatory bowel disease (IBD). Therefore, here we evaluated the role of these glands in experimental colitis induced by 3% dextran sulfate sodium (DSS) in C57BL/6 mice subjected to adrenalectomy, with or without glucocorticoid (GC) replacement. Mice succumbed to colitis without adrenals with a higher clinical score and augmented systemic levels of IL-6 and lower LPS. Furthermore, adrenalectomy negatively modulated systemic regulatory markers. The absence of adrenals resulted in augmented tolerogenic lamina propria dendritic cells but no compensatory local production of corticosterone and decreased mucosal inflammation associated with increased IFN-γ and FasL in the intestine. To clarify the importance of GC in this scenario, GC replacement in adrenalectomized mice restored different markers to the same degree of that observed in DSS group. Finally, this is the first time that adrenal-derived hormones, especially GC, were associated with the differential local modulation of the gut infiltrate, also pointing to a relationship between adrenalectomy and the modulation of systemic regulatory markers. These findings may elucidate some neuroimmunoendocrine mechanisms that dictate colitis outcome.


Asunto(s)
Glándulas Suprarrenales/metabolismo , Colitis/inmunología , Adrenalectomía , Animales , Colitis/inducido químicamente , Dexametasona/farmacología , Sulfato de Dextran/toxicidad , Ensayo de Inmunoadsorción Enzimática , Proteína Ligando Fas/metabolismo , Citometría de Flujo , Glucocorticoides/farmacología , Interferón gamma/metabolismo , Mucosa Intestinal/metabolismo , Lipopolisacáridos/farmacología , Masculino , Ratones Endogámicos C57BL
19.
J Magn Reson Imaging ; 42(6): 1582-91, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25920494

RESUMEN

BACKGROUND: Glioblastoma is a malignant World Health Organization (WHO) grade IV glioma with a poor prognosis in humans. New therapeutics are desperately required. The nitrone OKN-007 (2,4-disulfophenyl-PBN) has demonstrated effective anti-glioma properties in several rodent models and is currently being used as a clinical investigational drug for recurrent gliomas. We assessed the regional effects of OKN-007 in the tumor necrotic core and non-necrotic tumor parenchyma. METHODS: An F98 rat glioma model was evaluated using proton magnetic resonance spectroscopy ((1) H-MRS), diffusion-weighted imaging (DWI), morphological T2-weighted imaging (T2W) at 7 Tesla (30 cm-bore MRI), as well as immunohistochemistry and microarray assessments, at maximum tumor volumes (15-23 days following cell implantation in untreated (UT) tumors, and 18-35 days in OKN-007-treated tumors). RESULTS: (1) H-MRS data indicates that Lip0.9/Cho, Lip0.9/Cr, Lip1.3/Cho, and Lip1.3/Cr ratios are significantly decreased (all P < 0.05) in the OKN-007-treated group compared with UT F98 gliomas. The Cho/Cr ratio is also significantly decreased in the OKN-007-treated group compared with UT gliomas. In addition, the OKN-007-treated group demonstrates significantly lower ADC values in the necrotic tumor core and the nonnecrotic tumor parenchyma (both P < 0.05) compared with the UT group. There was also an increase in apoptosis following OKN-007 treatment (P < 0.01) compared with UT. CONCLUSION: OKN-007 reduces both necrosis and tumor cell proliferation, as well as seems to mediate multiple effects in different tumor regions (tumor necrotic core and nonnecrotic tumor parenchyma) in F98 gliomas, indicating the efficacy of OKN-007 as an anti-cancer agent and its potential clinical use.


Asunto(s)
Bencenosulfonatos/administración & dosificación , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/patología , Glioma/tratamiento farmacológico , Glioma/patología , Iminas/administración & dosificación , Imagen por Resonancia Magnética/métodos , Administración Oral , Animales , Antineoplásicos/administración & dosificación , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Humanos , Necrosis/patología , Necrosis/prevención & control , Ratas , Ratas Endogámicas F344
20.
Biochim Biophys Acta ; 1832(12): 2153-61, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23959048

RESUMEN

Free radicals play a major role in gliomas. By combining immuno-spin-trapping (IST) and molecular magnetic resonance imaging (mMRI), in vivo levels of free radicals were detected within mice bearing orthotopic GL261 gliomas. The nitrone spin trap DMPO (5,5-dimethyl pyrroline N-oxide) was administered prior to injection of an anti-DMPO probe (anti-DMPO antibody covalently bound to a bovine serum albumin (BSA)-Gd (gadolinium)-DTPA (diethylene triamine penta acetic acid)-biotin MRI contrast agent) to trap tumor-associated free radicals. mMRI detected the presence of anti-DMPO adducts by either a significant sustained increase (p<0.001) in MR signal intensity or a significant decrease (p<0.001) in T1 relaxation, measured as %T1 change. In vitro assessment of the anti-DMPO probe indicated a significant decrease (p<0.0001) in T1 relaxation in GL261 cells that were oxidatively stressed with hydrogen peroxide, compared to controls. The biotin moiety of the anti-DMPO probe was targeted with fluorescently-labeled streptavidin to locate the anti-DMPO probe in excised brain tissues. As a negative control a non-specific IgG antibody covalently bound to the albumin-Gd-DTPA-biotin construct was used. DMPO adducts were also confirmed in tumor tissue from animals administered DMPO, compared to non-tumor brain tissue. GL261 gliomas were found to have significantly increased malondialdehyde (MDA) protein adducts (p<0.001) and 3-nitrotyrosine (3-NT) (p<0.05) compared to normal mouse brain tissue, indicating increased oxidized lipids and proteins, respectively. Co-localization of the anti-DMPO probe with either 3-NT or 4-hydroxynonenal was also observed. This is the first report regarding the detection of in vivo levels of free radicals from a glioma model.


Asunto(s)
Neoplasias Encefálicas/metabolismo , Óxidos N-Cíclicos/inmunología , Modelos Animales de Enfermedad , Radicales Libres/análisis , Glioma/metabolismo , Imagen por Resonancia Magnética , Detección de Spin , Albúminas , Animales , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/patología , Medios de Contraste , Radicales Libres/aislamiento & purificación , Gadolinio DTPA , Glioma/diagnóstico por imagen , Glioma/patología , Inmunoglobulina G/farmacología , Ratones , Ratones Endogámicos C57BL , Óxidos de Nitrógeno/metabolismo , Oxidación-Reducción , Radiografía , Marcadores de Spin/síntesis química , Células Tumorales Cultivadas , Tirosina/análogos & derivados , Tirosina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA